Antibiotics as infrastructure
What would happen to the healthcare system without antibiotics? The responsible use of antibiotics requires minimizing their usage, which discourages...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01CRA's advises on Hologic’s acquisition of EndomagneticsOn July 25, 2024, Hologic completed its acquisition of Endomagnetics. CRA expert, Dr. Elizabeth M. Bailey, provided economic assistance to Hologic on...View engagement
- 02European Commission fines Teva €462.6 million for antitrust abuseThe Commission found that Teva had abused its dominant position by engaging in two types of conduct. First, it misused the patent system to artificially...View engagement
- 03Creating a consortium of experts to lead fundamental advancements in subcutaneous (SC) drug development and deliveryClient issue A group of leading formulation scientists and device developers in pharma and biotech from 15+ organizations sought expertise and guidance in...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsLatest insights
Recent events
ISPOR Europe 2024
CRA had four posters accepted at the conference. Kirsten Axelsen and Charlotte Poon present their poster titled “Assessing the economic burden of rare disease...
16th Medicine Forum
Antun Sablek is the keynote speaker during the session discussing the implementation of the new European Health Technology Assessment (HTA) regulation,...